Literature DB >> 11122248

Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.

R S Weening1, M De Boer, T W Kuijpers, V M Neefjes, W W Hack, D Roos.   

Abstract

Chronic granulomatous disease (CGD) is a clinical syndrome of recurrent bacterial and fungal infections caused by a rare disorder of phagocytic cells. In CGD, the phagocytes are unable to generate oxygen radicals after stimulation of these cells, due to a defect in the NADPH oxidase system. This NADPH oxidase is a multicomponent enzyme of at least four subunits, of which the beta-subunit of cytochrome b558, gp91-phox, is encoded by an X-linked gene (called CYBB). We report here five patients from two families; in each family we found a different mutation in the promoter region of CYBB. Both mutations prevented the expression of gp91-phox in the patients' neutrophils and thus caused inability of these cells to generate oxygen radicals. However, the mutations left the gp91-phox expression and the function of the NADPH oxidase in the patients' eosinophils intact. The relatively mild course of the CGD in these patients can probably be attributed to the fact that the eosinophils have retained their oxidative capacity. Furthermore, our results indicate that neutrophils and eosinophils differ in their regulation of gp91-phox expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122248      PMCID: PMC1905790          DOI: 10.1046/j.1365-2249.2000.01405.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123.

Authors:  G Rothe; A Emmendörffer; A Oser; J Roesler; G Valet
Journal:  J Immunol Methods       Date:  1991-04-08       Impact factor: 2.303

2.  PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytes.

Authors:  S Suzuki; A Kumatori; I A Haagen; Y Fujii; M A Sadat; H L Jun; Y Tsuji; D Roos; M Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Purification and cryopreservation of phagocytes from human blood.

Authors:  D Roos; M de Boer
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components.

Authors:  M T Quinn; T Evans; L R Loetterle; A J Jesaitis; G M Bokoch
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

5.  Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils.

Authors:  R S Weening; L H Adriaansz; C M Weemaes; R Lutter; D Roos
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

6.  Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity.

Authors:  D Diekmann; A Abo; C Johnston; A W Segal; A Hall
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

7.  A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.

Authors: 
Journal:  N Engl J Med       Date:  1991-02-21       Impact factor: 91.245

8.  Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000.

Authors:  C A Parkos; R A Allen; C G Cochrane; A J Jesaitis
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes.

Authors:  A W Segal; I West; F Wientjes; J H Nugent; A J Chavan; B Haley; R C Garcia; H Rosen; G Scrace
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

10.  Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease.

Authors:  A W Segal
Journal:  Nature       Date:  1987 Mar 5-11       Impact factor: 49.962

View more
  8 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

3.  Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.

Authors:  Marie José Stasia; Pierre Bordigoni; Daniel Floret; Jean Paul Brion; Cécile Bost-Bru; Gérard Michel; Pierre Gatel; Denis Durant-Vital; Marie Antoinette Voelckel; Xing Jun Li; Michèle Guillot; Elisabeth Maquet; Cécile Martel; Françoise Morel
Journal:  Hum Genet       Date:  2004-11-06       Impact factor: 4.132

Review 4.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

5.  Late diagnosis and advances in genetics of chronic granulomatous disease.

Authors:  G Di Matteo; A Finocchi
Journal:  Clin Exp Immunol       Date:  2020-12-13       Impact factor: 4.330

6.  Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn.

Authors:  Milica Miladinovic; Boris Wittekindt; Sebastian Fischer; Elise Gradhand; Steffen Kunzmann; Stefanie Y Zimmermann; Shahrzad Bakhtiar; Thomas Klingebiel; Rolf Schlösser; Thomas Lehrnbecher
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

7.  Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.

Authors:  M Mollin; S Beaumel; B Vigne; J Brault; N Roux-Buisson; J Rendu; V Barlogis; G Catho; C Dumeril; F Fouyssac; D Monnier; V Gandemer; M Revest; J-P Brion; C Bost-Bru; E Jeziorski; L Eitenschenck; C Jarrasse; S Drillon Haus; M Houachée-Chardin; M Hancart; G Michel; Y Bertrand; D Plantaz; J Kelecic; R Traberg; L Kainulainen; J Fauré; F Fieschi; M J Stasia
Journal:  Clin Exp Immunol       Date:  2020-10-12       Impact factor: 4.330

Review 8.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.